Pathomechanism of insulin resistance in chronic hepatitis C;Patomechanizm insulinooporności w przewlekłym wirusowym zapaleniu wa̧troby typu C

Przeglad Gastroenterologiczny

Volumn 6, Issue 5, 2011, Pages 284-289

  Kukla, Michał ^a,b   Sawczyn, Tomasz ^a   Zwirska Korczala, Krystyna ^a   Jarosz, Mirosław ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Klinika Chorób Metabolicznych I Gastroenterologii Instytutu Zywno ci I Zywienia   (Poland)

Author keywords

Adipokines; Chronic hepatitis C; Fibrosis; Insulin resistance; Liver

Indexed keywords

ANTIVIRUS AGENT; CYTOKINE;

ANTIVIRAL THERAPY; DISEASE COURSE; FATTY LIVER; GLUCOSE TOLERANCE; HEPATITIS C; INSULIN RESISTANCE; LIVER CELL CARCINOMA; LIVER FIBROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; UPREGULATION;

EID: 81855180750     PISSN: 18955770     EISSN: 18974317     Source Type: Journal    
DOI: 10.5114/pg.2011.25376     Document Type: Review

References (51)

1. Allison ME, Wreghitt T, Palmer CR, et al. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994; 21: 1135-9.
2. Mason AL, Lau JY, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29: 32-3.
3. Caronia S, Taylor K, Pagliaro L, et al. Further evidence for an association between non-insulindependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 30: 1059-63. (Pubitemid 29458297)
4. Zein NN, Abdulkarim AS, Wiesner RH, et al. Prevalence of diabetes mellitus in patients with endstage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol 2000; 32: 209-17. (Pubitemid 30093899)
5. Zein CO, Levy C, Basu A, et al. Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Am J Gastroenterol 2005; 100: 48-55. (Pubitemid 41623268)
6. Mehta SH, Brancati FL, Sulkowski MS, et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-9.
7. Mehta SH, Brancati FL, Strathdee SA, et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 2003; 38: 50-6. (Pubitemid 36775795)
8. Pazienza V, Clement S, Pugnale P, et al. The hepatitis C virus core protein of genotypes 3a and 1b down-regulates insulin receptor substrate 1 through genotype-specific mechanisms. Hepatology 2007; 45: 1164-71. (Pubitemid 46775778)
9. Kukla M, Żwirska-Korczala K, Gabriel A, et al. Chemerin, vaspin and insulin resistance in chronic hepatitis C. J Viral Hepat 2010; 17: 661-7.
10. Moucari R, Asselah T, Cazals-Hatern D, et al. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 2008; 134: 416-23. (Pubitemid 351181308)
11. Wawrzynowicz-Syczewska M, Brzeska A, Laurans Ł, et al. Lipid metabolism differs in chronic C hepatitis associated steatosis and non-alcoholic fatty liver disease. Exp Clin Hep 2008; 4: 35-8.
12. Sefraty L, Capeau J. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data. Liver Int 2009; 29 (Supl. 2): 13-25.
13. Hui JM, Sud A, Farrell GC, et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology 2003; 125: 1695-704. (Pubitemid 37500434)
14. Del Campo J, Romero-Gomez M. Steatosis and insulin resistance in hepatitis C: a way out for the virus. World J Gastroenterol 2009; 15: 5014-9.
15. Douglas MW, George J. Molecular mechanisms of insulin resistance in chronic hepatitis C. World J Gastroenterol 2010; 15: 4356-64.
16. Garcia-Compeon D, Jaquez-Quintana JO, Gonzalae-Gonzalez JA, et al. Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol 2009; 15: 280-8.
17. Harrison SA. Correlation between insulin resistance and hepatitis C viral load. Hepatology 2006; 43: 1168; author reply 1168-9.
18. Hsu CS, Liu CJ, Liu CH, et al. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C. Liver Int 2008; 28: 271-7. (Pubitemid 351201041)
19. Ratziu V, Munteanu M, Charlotte F, et al. LIDO Study Group. Fibrogenic impact of high serum glucose in chronic hepatitis C. J Hepatol 2003; 39: 1049-55. (Pubitemid 37523779)
20. Veldt BJ, Chen W, Heathcote EJ, et al. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 2008; 47: 1856-62. (Pubitemid 351945553)
21. Hung CH, Wang JH, Hu TH, et al. Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection. World J Gastroenterol 2010; 16: 2265-71.
22. Romero-Gomez M, Del Mar Viloria M, Andrade RJ, et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005; 128: 636-41. (Pubitemid 40585366)
23. Romero-Gomez M, Fernandez-Rodriguez CM, Andrade RJ, et al. Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C. J Hepatol 2008; 48: 721-7.
24. Lecube A, Hernandez C, Simo R, et al. Glucose abnormalities are an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. Am J Gastroenterol 2007; 102: 2189-95. (Pubitemid 47493841)
25. Poustchi H, Negro F, Hui J, et al. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3. J Hepatol 2008; 48: 28-34. (Pubitemid 350191982)
26. Nasta P, Gatti F, Puoti M, et al. Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferonalfa-2a. Aids 2008; 22: 857-61. (Pubitemid 351563835)
27. Kawaguchi Y, Mizuta T, Oza N, et al. Eradication of hepatitis C virus by interferon improves whole-body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C. Liver Int 2009; 29: 871-7.
28. Kawaguchi T, Ide T, Taniguchi E, et al. Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2. Am J Gastroenterol 2007; 102: 570-6. (Pubitemid 46328143)
29. Aytug S, Reich D, Sapiro LE, et al. Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 2003; 38: 1384-92. (Pubitemid 37466964)
30. Bernsmeier C, Duong FH, Christen V, et al. Virus induced overexpression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C. J Hepatol 2008; 49: 429-40.
31. Duong FH, Filipowicz M, Tripodi M, et al. Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology 2004; 126: 263-77. (Pubitemid 38040741)
32. Christen V, Treves S, Duong FH, et al. Activation of endoplasmic reticulum stress response by hepatitis viruses up-regulates protein phosphatase 2A. Hepatology 2007; 46: 558-65. (Pubitemid 47344792)
33. Shaw RJ, Lamia KA, Vasquez D, et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005; 310: 1642-6. (Pubitemid 41780780)
34. Kawaguchi T, Nagao Y, Tanaka K, et al. Causal relationship between hepatitis C virus core and the development of type 2 diabetes mellitus in a hepatitis C virus hyperendemic area: a pilot study. Int J Mol Med 2005; 16: 109-14.
35. Persico M, Capasso M, Persico E, et al. Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: insulin resistance and response to antiviral therapy. Hepatology 2007; 46: 1009-15. (Pubitemid 350144765)
36. Walsh MJ, Jonsson JR, Richardson MM, et al. Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signaling 3 (SOCS3) in patients with chronic hepatitis C, viral genotype 1. Gut 2006; 55: 529-35.
37. Ueki K, Kondo T, Kahn CR. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol 2004; 24: 5434-46. (Pubitemid 38738176)
38. Ueki K, Kondo T, Tseng YH, et al. Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci USA 2004; 101: 10422-7. (Pubitemid 38924941)
39. Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005; 42: 987-1000. (Pubitemid 43112663)
40. Durante-Mangoni E, Zampino R, Marrone A, et al. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumor necrosis factor-alpha in chronic hepatitis C patients. Aliment Pharmacol Ther 2006; 24: 1349-57. (Pubitemid 44571565)
41. Cua IH, Hui JM, Bandara P, et al. Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines. Hepatology 2007; 46: 66-73. (Pubitemid 47171922)
42. Żwirska-Korczala K, Kukla M, Ziółkowski A, et al. Leptin, neopterin and hepatocyte growth factor as markers of fibrosis and inflammatory activity in chronic hepatitis C. Exp Clin Hep 2005; 1: OR60-5.
43. Kukla M, Warakomska I, Gabriel A, et al. Serum levels of sICAM-1, TNF-alpha, sTNF-R1, and sTNF-R2 in patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin. Exp Clin Hep 2008; 4: OR12-20.
44. Knobler H, Zhornicky T, Sandler A, et al. Tumor necrosis factoralpha- induced insulin resistance may mediate the hepatitis C virus-diabetes association. Am J Gastroenterol 2003; 98: 2751-6.
45. Senn JJ, Klover PJ, Nowak IA, et al. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 2002; 51: 3391-9. (Pubitemid 35403441)
46. Klover PJ, Zimmers TA, Koniaris LG, et al. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 2003; 52: 2784-9. (Pubitemid 37339708)
47. Arkan MC, Hevener AL, Greten FR, et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005; 11: 191-8. (Pubitemid 40321355)
48. Maeno T, Okumura A, Ishikawa T, et al. Mechanisms of increased insulin resistance in non-cirrhotic patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 2003; 18: 1358-63. (Pubitemid 38045848)
49. Kukla M, Żwirska-Korczala K, Gabriel A, et al. Visfatin serum levels in chronic hepatitis C patients. J Viral Hepat 2010; 17: 254-60.
50. Choi SH, Park KJ, Ahn BY, et al. Hepatitis C virus nonstructural 5B protein regulates tumor necrosis factor alpha signaling through effect on cellular IkappaB kinase. Mol Cell Biol 2006; 26: 3048-59.
51. Bureau C, Bernard J, Chaouche N, et al. Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J Biol Chem 2001; 276: 23077-83.